True Digital Surgery is a technology company.
True Digital Surgery has raised $300K across 1 funding round.
True Digital Surgery has raised $300K in total across 1 funding round.
True Digital Surgery (TDS) is a technology company specializing in advanced image processing software and medical device hardware for robotically controlled 3D digital visualization and navigation in microsurgery. Their flagship product, the RE3 Robotic Exoscope, combines 3D visualization and guidance software to enhance surgical precision, comfort, and collaboration in the operating room. TDS serves surgeons and medical teams by solving the problem of limited visualization and physical strain associated with traditional ocular microscopes, enabling improved decision-making and patient outcomes through real-time augmented reality and AI integration. The company has demonstrated strong growth momentum by evolving its technology over two decades and securing partnerships with leading life sciences organizations[1][4].
Founded in 2003, True Digital Surgery evolved from an earlier entity called TrueVision Systems, established in 2007, with a mission to revolutionize surgical visualization through digital microscopy. The founders and early team focused on eliminating the need for surgeons to look through traditional microscopes by developing a “heads-up” high-definition view of anatomy and vascular systems. This innovation marked a pivotal moment, leading to the development of whole product solutions that integrate software and hardware for computer-guided microsurgery. Over time, TDS expanded its capabilities to include robotic control, augmented reality, and AI, positioning itself as a world leader in computer-guided microsurgery[1].
True Digital Surgery rides the trend of digital transformation in healthcare, particularly the shift toward minimally invasive, robot-assisted surgeries enhanced by real-time data and visualization technologies. The timing is critical as surgical teams demand higher precision, reduced physical strain, and better collaborative tools in increasingly complex procedures. Market forces such as aging populations, rising demand for advanced surgical solutions, and growing adoption of AI and robotics in medicine favor TDS’s offerings. By pushing the boundaries of surgical visualization and ergonomics, TDS influences the broader ecosystem by setting new standards for surgical technology integration and multidisciplinary collaboration[1][4].
Looking ahead, True Digital Surgery is poised to expand its influence by further integrating AI-driven analytics and augmented reality to enhance surgical planning and intraoperative guidance. Trends such as personalized medicine, remote surgery assistance, and increased automation in the operating room will shape its trajectory. As the company continues to innovate, it may broaden its product portfolio and deepen partnerships with healthcare providers and device manufacturers, solidifying its role as a key enabler of next-generation microsurgery. The continued focus on surgeon comfort, precision, and team collaboration will remain central to its growth and impact[1][4].
True Digital Surgery has raised $300K in total across 1 funding round.
True Digital Surgery has raised $300K across 1 funding round. Most recently, it raised $300K Series A in May 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2019 | $300K Series A |